Funding search · EIN 042103547 · Boston, MA
Trustees of Boston University
A grantmaking public charity (files IRS Form 990, Schedule I). Charities like this often run real grant programs with application cycles.
- 1,097
- grants reported
- $445.0M
- total given
- 2021–2024
- filing years
- $115,559
- median grant
Based on grants this organization reported to the IRS for tax years 2021–2024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.
What they fund
Funder website ↗Full IRS filings ↗How this is builtReport an error
Funding pattern
What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.
Where the money goes
- Antibacterial and antifungal drug developers, mostly small biotech companies
- Rapid infectious-disease diagnostics firms (Visby, Avails, Day Zero, Pearl)
- Boston teaching hospitals: MGH, Boston Medical Center, Brigham, BIDMC
- Multi-site university subawards on clinical and translational studies
- Phage therapy and microbiome therapeutics (Locus, Vedanta)
- Global health delivery partners such as CHAI and JSI
Typical grant
Median is $115,559, with the middle half between $34,317 and $339,482, so most of the file is ordinary subaward-scale money. The checks above $2 million go almost entirely to antibacterial and diagnostics companies (Day Zero $5.3M, Cellics $5.0M, Locus $3.8M, Visby $3.6M) plus MGH and Harvard; the small ones are academic sites on multi-center studies. With 1,097 payments to 683 recipients across four years, renewal across years is the norm rather than the exception.
Their words
Phrases from their own grant descriptions, worth speaking back to them.
- “RESEARCH”
- “INC”
- “REGENTS OF THE UNIVERSITY OF”
- “BOARD OF TRUSTEES OF”
Positioning adjacent work
- Treat this as subaward flow, not philanthropy. Find the BU prime-award PI, not a program officer.
- Anchor to drug-resistant bacterial infection: therapeutics, phage, or point-of-care diagnostics. That is where the largest checks sit.
- Ask in the $50K to $350K range as a site or core; multimillion asks go to product developers.
- If you run a clinical site or assay core, pitch enrollment capacity or a validated readout, not novel discovery.
Worth knowing: This is a university's outbound research money, so the pattern is relationship-driven through BU faculty and existing consortium structures rather than open review. Massachusetts takes 249 of 1,097 grants, and the presence of dozens of for-profit biotech recipients points to an antibacterial accelerator portfolio absorbing most of the large-dollar giving.
Top recipients
Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.
- Pattern Bioscience2 grants · $11.4M
- The General Hospital Corporation2 grants · $10.6M
- Day Zero Diagnostics2 grants · $10.1M
- Peptilogics2 grants · $8.4M
- The General Hospital Corporation2 grants · $7.9M
- President & Fellows of Harvard Coll2 grants · $7.5M
- Day Zero Diagnostics2 grants · $7.2M
- Clarametyx Biosciences2 grants · $6.8M
- Glaxosmithkline Holdings Americas1 grant · $6.2M
- Cellics Therapeutics2 grants · $5.8M
Giving over time
Grant history
The 100 largest of 1,097 grants.
- $8.0M
Pattern Bioscience · Austin, TX · 2021
Research
- $6.9M
Day Zero Diagnostics · Boston, MA · 2022
Research Research
- $6.2M
Glaxosmithkline Holdings Americas · Philadelphia, PA · 2021
Research
- $5.5M
Clarametyx Biosciences · Columbus, OH · 2021
Research
- $5.5M
The General Hospital Corporation · Boston, MA · 2023
Research
- $5.4M
The General Hospital Corporation · Boston, MA · 2022
Research Research
- $5.3M
Day Zero Diagnostics · Boston, MA · 2024
Research
- $5.1M
The General Hospital Corporation · Boston, MA · 2024
Research
- $5.0M
Cellics Therapeutics · San Diego, CA · 2024
Research
- $4.8M
Peptilogics · Pittsburgh, PA · 2021
Research
- $4.4M
President & Fellows of Harvard Coll · Boston, MA · 2024
Research
- $3.8M
Avails Medical · Menlo Park, CA · 2022
Research Research
- $3.8M
Locus Biosciences · Morrisville, NC · 2024
Research
- $3.6M
Peptilogics · Pittsburgh, PA · 2022
Research Research
- $3.6M
Visby Medical · San Jose, CA · 2024
Research
- $3.6M
Amicrobe · Carlsbad, CA · 2021
Research
- $3.4M
Pattern Bioscience · Austin, TX · 2022
Research Research
- $3.4M
Vaxcyte · San Carlos, CA · 2022
Research Research
- $3.4M
Regents Univ of Ca Los Angeles · Los Angeles, CA · 2023
Research
- $3.3M
Affinivax · Cambridge, MA · 2021
Research
- $3.3M
Massachusetts Institute of Technoloy · Cambridge, MA · 2023
Research
- $3.2M
Day Zero Diagnostics · Boston, MA · 2021
Research
- $3.1M
Contrafect Corp · Yonkers, NY · 2021
Research
- $3.1M
President & Fellows of Harvard Coll · Boston, MA · 2023
Research
- $3.1M
Avails Medical · Menlo Park, CA · 2023
Research
- $3.0M
Boston Medical Center · Boston, MA · 2024
Research
- $2.9M
Integrated Biotherapeutics · Rockville, MD · 2021
Research
- $2.9M
Regents Univ of Ca Los Angeles · Los Angeles, CA · 2022
Research Research
- $2.9M
Lumen Bioscience · Seattle, WA · 2022
Research Research
- $2.9M
Boston Medical Center Corporation · Boston, MA · 2023
Research
- $2.8M
Vaxcyte · San Carlos, CA · 2023
Research
- $2.7M
Avails Medical · Menlo Park, CA · 2024
Research
- $2.6M
Entasis Therapeutics · Waltham, MA · 2021
Research
- $2.5M
The Regents of the University of Ca · Los Angeles, CA · 2023
Research
- $2.5M
Micurx Pharmaceuticals · Palo Alto, CA · 2021
Research
- $2.5M
The General Hospital Corporation · Boston, MA · 2021
Research
- $2.4M
Regents Univ of Ca Los Angeles · Los Angeles, CA · 2024
Research
- $2.4M
Lumen Bioscience · Seattle, WA · 2021
Research
- $2.4M
Microbion Corporation · Bozeman, MT · 2021
Research
- $2.3M
Boston Medical Center · Boston, MA · 2021
Research
- $2.2M
Cellics Therapeutics · San Diego, CA · 2021
Research
- $2.2M
Massachusetts Institute of Technolo · Cambridge, MA · 2022
Research Research
- $2.2M
The Regents of the University of Ca · Los Angeles, CA · 2024
Research
- $2.2M
University Corporation for Atmospheric · Birmingham, AL · 2021
Research
- $2.1M
Baebies · Durham, NC · 2022
Research Research
- $2.1M
The Regents of the University of Ca · Los Angeles, CA · 2022
Research Research
- $2.1M
The Regents of the University of Mi · Pittsburgh, PA · 2023
Research
- $2.0M
Boston Medical Center · Boston, MA · 2022
Research Research
- $2.0M
Amicrobe · Carlsbad, CA · 2022
Research Research
- $2.0M
Regents Univ of Ca Los Angeles · Los Angeles, CA · 2021
Research
- $2.0M
Locus Biosciences · Morrisville, NC · 2023
Research
- $2.0M
Vedanta Biosciences · Cambridge, MA · 2022
Research Research
- $2.0M
Regents of the University of Califo · Los Angeles, CA · 2024
Research
- $2.0M
Vanderbilt University · Dallas, TX · 2024
Research
- $2.0M
Massachusetts Institute of Technolo · Cambridge, MA · 2024
Research
- $2.0M
University of Alabama at Birmingham · Birmingham, AL · 2024
Research
- $2.0M
University of Massachusetts · North Dartmouth, MA · 2024
Research
- $1.9M
Vedanta Biosciences · Cambridge, MA · 2024
Research
- $1.9M
University of Pennsylvania · Philadelphia, PA · 2021
Research
- $1.8M
Day Zero Diagnostics · Boston, MA · 2023
Research
- $1.8M
President & Fellows of Harvard Coll · Boston, MA · 2022
Research Research
- $1.8M
Massachusetts Institute of Technologt · Cambridge, MA · 2021
Research
- $1.8M
The Regents of the University of Mi · Ann Arbor, MI · 2021
Research
- $1.8M
The Regents of the University of Mi · Pittsburgh, PA · 2024
Research
- $1.8M
Trellis Bioscience · Redwood City, CA · 2021
Research
- $1.7M
The Broad Institute · Cambridge, MA · 2024
Research
- $1.7M
President & Fellows of Harvard College · Boston, MA · 2021
Research
- $1.7M
The University of Iowa · Iowa City, IA · 2024
Research
- $1.7M
Vedanta Biosciences · Cambridge, MA · 2021
Research
- $1.7M
Novel Microdevices · Baltimore, MD · 2021
Research
- $1.6M
Regents of the University of California · Los Angeles, CA · 2021
Research
- $1.6M
Locus Biosciences · Morrisville, NC · 2021
Research
- $1.6M
Vaxcyte · San Carlos, CA · 2021
Research
- $1.6M
Trellis Bioscience · Redwood City, CA · 2022
Research Research
- $1.6M
The Brigham & Womens Hospital · Boston, MA · 2021
Research
- $1.6M
American College of Radiology · Reston, VA · 2021
Research
- $1.6M
Avails Medical · Menlo Park, CA · 2021
Research
- $1.6M
Helixbind · Marlborough, MA · 2021
Research
- $1.5M
Yeshiva University · Bronx, NY · 2022
Research Research
- $1.4M
Baebies · Durham, NC · 2021
Research
- $1.4M
State of Maryland · College Park, MD · 2024
Research
- $1.4M
Bugworks Research · Fremont, CA · 2021
Research
- $1.4M
Beth Israel Deaconess Medical Cente · Boston, MA · 2024
Research
- $1.4M
Beth Israel Deaconess Medical Cente · Boston, MA · 2023
Research
- $1.4M
Integrated Biotherapeutics · Rockville, MD · 2022
Research Research
- $1.4M
Macro Biologics · Carlsbad, CA · 2024
Research
- $1.4M
Vedanta Biosciences · Cambridge, MA · 2023
Research
- $1.4M
Clinton Health Access Initiative in · Boston, MA · 2024
Research
- $1.3M
The University of Iowa · Iowa City, IA · 2023
Research
- $1.3M
Rector and Visitors of the Univ of · Charlottesville, VA · 2021
Research
- $1.3M
The Regents of the University of Mi · Pittsburgh, PA · 2022
Research Research
- $1.3M
University of Washington · Chicago, IL · 2022
Research Research
- $1.3M
The Brigham & Womens Hospital · Boston, MA · 2023
Research
- $1.3M
The Trustees of Columbia University · New York, NY · 2023
Research
- $1.3M
Venatorx Pharmaceuticals · Malvern, PA · 2021
Research
- $1.3M
University of Alabama at Birmingham · Birmingham, AL · 2022
Research Research
- $1.3M
Clarametyx Biosciences · Columbus, OH · 2022
Research Research
- $1.3M
Lytica Therapeutics · Boston, MA · 2021
Research
- $1.3M
Novel Microdevices Llc · Baltimore, MD · 2021
Research
- $1.2M
University of Alabama at Birmingham · Birmingham, AL · 2023
Research
Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.
Search funders like this oneSource: IRS Form 990, Schedule I, as filed by this organization. These are grants already paid. Grants paid directly to individuals are reported to the IRS only as totals, so they do not appear as named lines here.

